Evidence of neurofeedback efficacy for ASD with and without seizures.

Autistic disorders are associated with brain abnormalities in function and connectivity with a high prevalence rate for related seizure disorders. There is emerging evidence to support the use of neurofeedback to treat these underlying neurophysiological disruptions. Efficacy rates are high with no enduring side effects. Specific advances in QEEG analysis have been recently applied with resulting neurofeedback approaches leading to high success rates for autistic symptoms and seizure events.Autistic disorders are associated with brain abnormalities in function and connectivity with a high prevalence rate for related seizure disorders. There is emerging evidence to support the use of neurofeedback to treat these underlying neurophysiological disruptions. Efficacy rates are high with no enduring side effects. Specific advances in QEEG analysis have been recently applied with resulting neurofeedback approaches leading to high success rates for autistic symptoms and seizure events.

Robert Coben, PhD, PhD

Licensed Psychologist in the state of NY with expertise in Neuropsychology, EEG and EEG biofeedback. Board certified in QEEG and EEG biofeedback. Recognized as a leading authority, researcher and clinician in the field of neurofeedback and autism.